company-logo

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

Cidara Therapeutics Dividend Announcement

Cidara Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Cidara Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Cidara Therapeutics Dividend History

Cidara Therapeutics Dividend Yield

Cidara Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cidara Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Cidara Therapeutics Financial Ratios

P/E ratio-1.01
PEG ratio-0.04
P/B ratio1.06
ROE-219.21%
Payout ratio0.00%
Current ratio3.54
Quick ratio3.54
Cash Ratio2.87

Cidara Therapeutics Dividend FAQ

Does Cidara Therapeutics stock pay dividends?
Cidara Therapeutics does not currently pay dividends to its shareholders.
Has Cidara Therapeutics ever paid a dividend?
No, Cidara Therapeutics has no a history of paying dividends to its shareholders. Cidara Therapeutics is not known for its dividend payments.
Why doesn't Cidara Therapeutics pay dividends?
There are several potential reasons why Cidara Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cidara Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cidara Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cidara Therapeutics a dividend aristocrat?
Cidara Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cidara Therapeutics a dividend king?
Cidara Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cidara Therapeutics a dividend stock?
No, Cidara Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cidara Therapeutics stocks?
To buy Cidara Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cidara Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.